Scientists from Duke-NUS Medical School have discovered that the protein IL11 accelerates aging, and targeting it with anti-IL11 therapy can reverse signs of aging in preclinical models, increasing lifespan by up to 25%. This therapy could have transformative effects on extending healthy years of life, addressing frailty, and improving cardiometabolic health.